# Efficacy and Safety of Adding Azarga to Prostaglandin Monotherapy

> **NCT00966576** · PHASE4 · COMPLETED · sponsor: **Alcon Research** · enrollment: 47 (actual)

## Conditions studied

- Glaucoma

## Interventions

- **DRUG:** Brinzolamide/Timolol Maleate Fixed Combination (AZARGA)

## Key facts

- **NCT ID:** NCT00966576
- **Lead sponsor:** Alcon Research
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-07
- **Primary completion:** 2010-08
- **Final completion:** 2010-08
- **Target enrollment:** 47 (ACTUAL)
- **Last updated:** 2016-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00966576

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00966576, "Efficacy and Safety of Adding Azarga to Prostaglandin Monotherapy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00966576. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*